In 87 patients with drug-resistant idiopathic generalised epilepsy, responsive centromedian thalamic stimulation did not significantly prolong time to second tonic-clonic seizure vs sham (primary endpoint null). Serious device-related event rate 6.9%, below the safety goal.
RCTn = 87
Uysal et al. Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months